Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile

BACKGROUND: Omalizumab is the first biological therapy used to treat moderate-to-severe asthma and certainly the one with the highest number of publications. METHODS: A systematic review and meta-analysis were performed to examine two critical outcomes of omalizumab therapy, asthma exacerbation rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenu, Grazia, La Tessa, Andrea, Calogero, Claudia, Lombardi, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020639/
https://www.ncbi.nlm.nih.gov/pubmed/36937051
http://dx.doi.org/10.3389/fped.2022.1033511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020639/
https://www.ncbi.nlm.nih.gov/pubmed/36937051
http://dx.doi.org/10.3389/fped.2022.1033511

Ejemplares similares